The main objective of this study is to investigate the potential contribution of the TGF‐β/Smads pathway to the effects of YXF, as well as the role of miR133a, through in vivo DCM models and in vitro experiments. This evidence concerns the gene TGFB1 and familial dilated cardiomyopathy.